Driehaus Capital Management LLC Tg Therapeutics, Inc. Transaction History

Driehaus Capital Management LLC

  • $9.27 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$6.68 - $18.81 $1.24 Million - $3.49 Million
185,441 New
185,441 $3.17 Million
Q2 2023

Aug 14, 2023
SELL
$15.48 - $35.0 $7.49 Million - $16.9 Million
-483,913 Reduced 57.08%
363,831 $9.04 Million
Q1 2023

May 15, 2023
BUY
$10.23 - $19.34 $8.67 Million - $16.4 Million
847,744 New
847,744 $12.8 Million

Others Institutions Holding TGTX

# of Institutions
287
Shares Held
91.8M
Call Options Held
1.9M
Put Options Held
1.45M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $3.46B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email